Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T13:06:00.291Z Has data issue: false hasContentIssue false
  • English
  • Français

Response of Depressive Symptoms to Nortriptyline, Phenelzine and Placebo

Published online by Cambridge University Press:  03 January 2018

Anastasios Georgotas ,
Robert E. Mccue ,
Eitan Friedman  and
Thomas B. Cooper
Anastasios Georgotas*
Affiliation:
Depression Studies Program
Robert E. Mccue
Affiliation:
Department of Psychiatry
Eitan Friedman
Affiliation:
New York University School of Medicine
Thomas B. Cooper
Affiliation:
Columbia University College of Physicians and Surgeons; Psychiatric Research, Analytical Psychopharmacology Laboratory, Nathan Kline Institute and New York State Psychiatric Institute
*
New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
Get access Rights & Permissions [Opens in a new window]

Extract

The effects of nortriptyline, phenelzine, and placebo on 13 symptoms of depression were compared in 75 patients, aged 55 or over, who were suffering from major depression. Nortriptyline and phenelzine were more effective than placebo in treating depression mood, guilt feelings, suicidal ideation, agitation, anxiety, loss of energy, and a.m. diurnal variation of mood. Nortriptyline was better than phenelzine or placebo in improving middle/late insomnia. Most of the symptoms did not show significant improvement until the fourth week of treatment.

Type
Papers
Information
The British Journal of Psychiatry , Volume 151 , Issue 1 , July 1987 , pp. 102 - 106
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bech, P., Allerup, P., Gram, L., Rebby, N., Rosenberg, R., Jacobsen, O. & Nagy, A. (1981) The Hamilton Rating Scale: evaluation of objectivity using logistic moders. Acta Psychiatrica Scandinavica, 63, 290–299.CrossRefGoogle Scholar
Georgotas, A., Mann, J. & Friedman, E. (1981) Platelet monoamine oxidase inhibition as a potential indicator of favorable responses to MAOIsin geriatric depression. Biological Psychiatry, 16, 997–1001.Google Scholar
Georgotas, A., Cooper, T., Km, M. & Hapworth, W. (1983) The treatment of affective disorders in the elderly. Psychopkarmacology Bulletin, 19, 226–237.Google Scholar
Georgotas, A., McCue, R. E., Km, O. M., Friedman, E., Hapworth, W., Welkowitz, J. & Cooper, T. (1986) Comparative efficacy and safety of MAOI's versus TCA's in treating depressed elderly. Biological Psychiatry.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Clinical and Social Psychology, 6, 278–296.CrossRefGoogle ScholarPubMed
Kay, D. W. K., Garsde, R. F. & Fahy, T. J. (1973) A double-blind trial pf phenelzine and amitriptyline in depressed out-patients: a possible differential effect of the drugs on symptoms. British Journal of Psychiatry, 123, 63–67.Google Scholar
Montgomery, S. A. & Asberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.Google Scholar
Nelson, J. C., Mazure, C., Quinlan, D. M. & Jatlow, P. I. (1984) Drug-responsive symptoms in melancholia. Archives of General Psychiatry, 41, 663–668 Google Scholar
Nms, A. (1984) Differential response patterns to MAO inhibitors and tricyclics. Journal of Clinical Psychiatry, 45, 70–77.Google Scholar
Overall, J. E. (1975) Distinguishing between patterns of drug indications and patterns of drug effects. Psychopharmacology Bulletin, 11, 17.Google ScholarPubMed
Paykel, E. S., Rowan, P. R., Parker, R. R. & Bhat, A. V. (1982) Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry, 39, 1041–1049.Google Scholar
Pedhazur, E. (1982) Multiple Regression in Behavioral Research, 2nd edn. New York: Holt, Rinehart, Winston.Google Scholar
Raskin, A., Schulterbrandt, J. G., Reatig, N., Chase, C. & McKbon, J. J. (1970) Differential response to chlorpromazine, imipramine, and placebo. Archives of General Psychiatry, 23, 164–173.CrossRefGoogle ScholarPubMed
Ravarb, C. L., Robinson, D. S., Ives, J. O. et al (1980) Phenelzine and amitriptyline in the treatment of depression. Archives of General Psychiatry, 37, 1075–1080.Google Scholar
Robinson, D. S., Nies, A., Ravaris, L., Ives, J. O. & Bartlett, D. (1978) Clinical pharmacology of phenelzine. Archives of General Psychiatry, 35, 629–635.Google Scholar
Sθrensen, B., Kragh-Sθrensen, P., Larsen, N.-E. & Hvidberg, E. F. (1978) The practical significance of nortriptyline plasma control: a prospective evaluation under routine conditions in endogenous depression. Psychopharmacology (Berlin), 59, 35–39.CrossRefGoogle Scholar
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry, 35, 837–844.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.